GlassScriptPhysician profile
Angela M Cain
NPI 1255801916
$1,281.39
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,001 · 2022: $280.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $211.63 | 2021-2022 | |
| Antares Pharma, INC. | $201.55 | 2021 | |
| Glaxosmithkline, LLC. | $130.59 | 2021-2022 | |
| Abbvie INC. | $102.35 | 2021 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Lilly USA, LLC | $71.03 | 2021-2022 | |
| Vistapharm, INC. | $64.41 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.79 | 2021 | |
| Lundbeck LLC | $39.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.72 | 2021-2022 | |
| Novo Nordisk INC | $38.21 | 2021-2022 | |
| Mannkind Corporation | $37.85 | 2021-2022 | |
| Esperion Therapeutics, INC. | $30.77 | 2021 | |
| Amgen INC. | $27.64 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $25.52 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $24.72 | 2021 | |
| Amarin Pharma, INC. | $20.82 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.71 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.48 | 2021 | |
| Merck Sharp & Dohme LLC | $14.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.59 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.